The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re the Acquisition of DT Ultravert

1 Oct 2020 11:41

RNS Number : 8244A
Path Investments plc
01 October 2020
 

Path Investments plc

("Path" or the "Company")

 

Further re the Acquisition of DT Ultravert

 

Acquisition of remaining 25% of DT Ultravert from Diversion Technologies LLC

 

Update on Acquisition of 75% of DT Ultravert and Kansas Land Leases from Zoetic International plc

 

 

Path Investments plc (TIDM: PATH), the energy and natural resources investment company, is pleased to announce certain updates regarding the Company's proposed acquisition of the patented proprietary technology, DT Ultravert ("DTU").

 

Acquisition of 25% of DT Ultravert from Diversion Technologies LLC

 

The Company is pleased to announce that it has entered into a binding agreement with Diversion Technologies LLC ("DTL") to acquire its 25% ownership of DTU, together with all associated applications and trademarks (the "Transaction").

 

The consideration for the Transaction will be satisfied by the issue by Path to DTL of 10,000,000 new ordinary shares in the Company, together with 5,000,000 warrants to subscribe for ordinary shares in Path at any time following completion at an exercise price of 1.5 pence per share.

 

Completion of the Transaction is subject to the publication of a prospectus by Path prepared in accordance with the Prospectus Regulation Rules made under section 73A of the Financial Services and Markets Act 2000 (as amended) and approved by the UK Financial Conduct Authority under section 87A of Financial Services and Markets Act 2000 (as amended) and readmission of Path's ordinary shares to the standard segment of the Official List maintained by the Financial Conduct Authority, and readmission to trading on the Main Market of the London Stock Exchange.

 

Update on the Acquisition of 75% of DT Ultravert and the Kansas Land Leases from Zoetic International plc

 

With the announcement today of our conditional acquisition of the remaining 25% of DTU, Path is pleased to reiterate its binding agreement with Zoetic International plc ("Zoetic").

 

The consideration for the acquisition of the other 75% of DT Ultravert and the Kansas Land Leases will be satisfied by the issue by Path to Zoetic of 15,000,000 warrants to subscribe for ordinary shares in Path at any time from the first to the third anniversaries following completion at an exercise price of 0.75 pence per share, together with 15,000,000 warrants to subscribe for ordinary shares in Path at any time from the first to the third anniversaries following completion at an exercise price of 1.5 pence per share.

 

Additionally, Path has agreed to pay, in perpetuity, to Zoetic a royalty equal to 6% of all gross revenues derived from its former 75% holding in DTU, accruing from receipt of first revenues, although not payable until 12 months thereafter. Royalty payments will be settled quarterly, with payments being made at the end of the quarter in which Path earns revenue. For the avoidance of doubt, Path has no obligation to make a payment to Zoetic unless it has received the revenue payment from its own customers.

 

Royalty payments due until the fifth anniversary of completion, at Path's discretion, may be settled as to 50 per cent. by the issue of new ordinary shares in Path, in which case the value of those ordinary shares will be based on the volume weighted average price over the 10 business days prior to the date of issue. Thereafter payments due will be settled in cash.

 

Zoetic will enter into an orderly marketing agreement in respect of the new ordinary shares of Path issued as consideration and any exercise of warrants for a period of 12 months from the date of completion.

 

Completion of the acquisition from Zoetic is subject to a number of items, including the publication of a prospectus by Path prepared in accordance with the Prospectus Regulation Rules made under section 73A of the Financial Services and Markets Act 2000 (as amended) and approved by the UK Financial Conduct Authority under section 87A of Financial Services and Markets Act 2000 (as amended) and readmission of Path's ordinary shares to the standard segment of the Official List maintained by the Financial Conduct Authority, and readmission to trading on the Main Market of the London Stock Exchange.

 

Commenting, Christopher Theis CEO of Path, said: "We are delighted to have agreed the acquisition of the remaining 25% of DTU, together with all associated applications and trademarks from Diversion Technologies LLC. Together with our acquisition of the 75% holding by Zoetic International plc, announced on 27 May 2020, this important transaction brings into our ownership 100% of the DTU technology.

 

"We are excited by the opportunities that 100% ownership of the technology brings to Path, and we believe we are well positioned to be able to exploit this exciting technology to ensure that its commercial benefits are maximised. As a re-fracking well stimulation and protection technology, DTU is a potentially more effective and cheaper method to stimulate and protect conventional and unconventional formations, together with providing environmental benefits."

 

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

IFC Advisory Limited (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

Grant Thornton UK LLP (Financial Adviser)

Samantha Harrison

020 7865 2411

Harrison Clarke

020 7184 4384

Keith, Bayley, Rogers & Co. Limited (Broker)

Brinsley Holman

07776 30 22 28

Graham Atthill-Beck

07506 43 41 07

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQKKDBQKBDDKKK
Date   Source Headline
7th Jul 20202:00 pmRNSUpdate on Acquisition
22nd Jun 20204:45 pmRNSFurther re Application for Lifting of Suspension
17th Jun 20207:00 amRNSFinancial Adviser Appointment
17th Jun 20207:00 amRNSDirector/PDMR Shareholding
12th Jun 20207:00 amRNSFundraising & Lifting of Suspension Application
27th May 20207:00 amRNSExpiry of Share Purchase Agreement with FineGems
27th May 20207:00 amRNSAcquisition of DTU and Kansas Nitrogen Reserves
20th May 202012:20 pmRNSResult of AGM
18th May 202011:59 amRNSChange of Registered Office
24th Apr 20207:00 amRNSNotice of AGM
24th Apr 20207:00 amRNSAppointment of Corporate Broker
21st Jan 20203:39 pmRNSUpdate and resignation of director
26th Sep 201912:44 pmRNSInterim Results
20th Aug 20197:00 amRNSNew Corporate Website
19th Aug 20197:00 amRNSProposed Acquisition of FineGems Extraction
28th Jun 20197:00 amRNSFinal Results for the Year Ended 31 December 2018
17th Jun 20199:52 amRNSCompany update
13th Mar 20197:00 amRNSWithdrawal from Proposed Transaction
1st Mar 20193:13 pmRNSUpdate on Heads of Agreement
1st Feb 20197:00 amRNSSale of Turkish interests
18th Jan 20197:01 amRNSInterim Results for the six months to 30 June 2018
18th Jan 20197:00 amRNSHeads of Agreement
5th Nov 20187:00 amRNSWithdrawal from proposed Farm-in Agreement
10th Oct 20184:00 pmRNSSchedule One Update - Path Investments Plc
25th Sep 20189:45 amRNSSch 1 Update - Path Investments Plc
4th Sep 20187:30 amRNSSch 1 Update - Path Investments Plc
28th Aug 201811:38 amRNSResult of AGM
6th Aug 20185:30 pmRNSSchedule One - Path Investments Plc
3rd Aug 20187:00 amRNSNotice of AGM
30th Jul 20187:00 amRNSProposed Placing to raise £10 million
29th Jun 20187:00 amRNSGeneral Meeting Statement
4th Jun 20183:49 pmRNSAnnual Report and Notice of GM (Replacement)
4th Jun 20182:13 pmRNSAvailability of Annual Report and Notice of AGM
4th Jun 20182:08 pmRNSAnnual Results for the year ended 31 December 2017
25th May 20182:57 pmRNSCompany Update
28th Mar 20187:00 amRNSUpdate re Intended Standard Listing cancellation
8th Mar 20187:00 amRNSUpdate re cancellation of standard listing
20th Feb 20187:00 amRNSUpdate on Well A-EZ Z4 (2)
7th Feb 20182:10 pmRNSUpdate re Proposed Farm-in Agreement
19th Jan 20184:31 pmRNSIntended cancellation of Standard Listing
15th Dec 20177:30 amRNSSuspension Path Investments plc
15th Dec 20177:00 amRNSFarm-in Agreement and Temporary Suspension
25th Sep 20177:00 amRNSInterim Results
26th Jul 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSHolding(s) in Company
5th Jun 20174:10 pmRNSHolding(s) in Company
23rd May 20173:47 pmRNSHolding(s) in Company
22nd May 201712:11 pmRNSResult of AGM
15th May 201710:29 amRNSPath Investments engagement via Vox Markets
11th May 20177:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.